NO20000079L - Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav - Google Patents
Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse deravInfo
- Publication number
- NO20000079L NO20000079L NO20000079A NO20000079A NO20000079L NO 20000079 L NO20000079 L NO 20000079L NO 20000079 A NO20000079 A NO 20000079A NO 20000079 A NO20000079 A NO 20000079A NO 20000079 L NO20000079 L NO 20000079L
- Authority
- NO
- Norway
- Prior art keywords
- ancrod
- mixtures
- derivatives
- monoclonal antibodies
- antibody fragments
- Prior art date
Links
- 108010001779 Ancrod Proteins 0.000 title 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title 1
- 229960004233 ancrod Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19729544A DE19729544A1 (de) | 1997-07-10 | 1997-07-10 | Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung |
| PCT/EP1998/003834 WO1999002564A2 (de) | 1997-07-10 | 1998-06-23 | Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000079D0 NO20000079D0 (no) | 2000-01-07 |
| NO20000079L true NO20000079L (no) | 2000-03-07 |
Family
ID=7835268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000079A NO20000079L (no) | 1997-07-10 | 2000-01-07 | Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6365155B1 (cs) |
| EP (1) | EP1000087A2 (cs) |
| JP (1) | JP2002511880A (cs) |
| KR (1) | KR20010021649A (cs) |
| CN (1) | CN1262690A (cs) |
| AU (1) | AU748841B2 (cs) |
| BR (1) | BR9810574A (cs) |
| CA (1) | CA2295218A1 (cs) |
| CZ (1) | CZ297216B6 (cs) |
| DE (1) | DE19729544A1 (cs) |
| IL (1) | IL133224A0 (cs) |
| NO (1) | NO20000079L (cs) |
| WO (1) | WO1999002564A2 (cs) |
| ZA (1) | ZA986064B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079944A1 (es) * | 2010-01-20 | 2012-02-29 | Boehringer Ingelheim Int | Anticuerpo neutralizante de la actividad de un anticoagulante |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3841736A1 (de) * | 1988-12-10 | 1990-07-05 | Basf Ag | Ancrod-proteine, ihre herstellung und verwendung |
| CA2015127A1 (en) * | 1989-04-26 | 1990-10-26 | John G. Gray, Jr. | Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof |
| DE69302719T2 (de) * | 1992-02-17 | 1996-09-19 | Akzo Nv | Kalibrator und Verwendung davon in einer Immuntest |
| US5523292A (en) * | 1992-10-14 | 1996-06-04 | Schwartz; Robert | Method of preventing restenosis following coronary angioplasty |
-
1997
- 1997-07-10 DE DE19729544A patent/DE19729544A1/de not_active Withdrawn
-
1998
- 1998-06-23 IL IL13322498A patent/IL133224A0/xx unknown
- 1998-06-23 EP EP98936383A patent/EP1000087A2/de not_active Withdrawn
- 1998-06-23 WO PCT/EP1998/003834 patent/WO1999002564A2/de active IP Right Grant
- 1998-06-23 AU AU85406/98A patent/AU748841B2/en not_active Ceased
- 1998-06-23 CN CN98807040A patent/CN1262690A/zh active Pending
- 1998-06-23 KR KR1020007000207A patent/KR20010021649A/ko not_active Withdrawn
- 1998-06-23 BR BR9810574-4A patent/BR9810574A/pt not_active Application Discontinuation
- 1998-06-23 CZ CZ20000057A patent/CZ297216B6/cs not_active IP Right Cessation
- 1998-06-23 CA CA002295218A patent/CA2295218A1/en not_active Abandoned
- 1998-06-23 JP JP50805199A patent/JP2002511880A/ja not_active Ceased
- 1998-06-23 US US09/446,983 patent/US6365155B1/en not_active Expired - Lifetime
- 1998-07-09 ZA ZA9806064A patent/ZA986064B/xx unknown
-
2000
- 2000-01-07 NO NO20000079A patent/NO20000079L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2295218A1 (en) | 1999-01-21 |
| JP2002511880A (ja) | 2002-04-16 |
| AU8540698A (en) | 1999-02-08 |
| WO1999002564A2 (de) | 1999-01-21 |
| EP1000087A2 (de) | 2000-05-17 |
| DE19729544A1 (de) | 1999-01-14 |
| WO1999002564A3 (de) | 1999-04-01 |
| IL133224A0 (en) | 2001-03-19 |
| BR9810574A (pt) | 2000-09-19 |
| KR20010021649A (ko) | 2001-03-15 |
| ZA986064B (en) | 2000-01-10 |
| CN1262690A (zh) | 2000-08-09 |
| CZ200057A3 (cs) | 2000-05-17 |
| AU748841B2 (en) | 2002-06-13 |
| US6365155B1 (en) | 2002-04-02 |
| CZ297216B6 (cs) | 2006-10-11 |
| NO20000079D0 (no) | 2000-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199501614A2 (tr) | Anti-alfa integrin monoklonal antikor. | |
| DK0941344T3 (da) | Humaniserede anti-CD11a-antistoffer | |
| NO996551L (no) | Forbedrete anti-IgE-antistoffer og fremgangsmåte for forbedring av polypeptider | |
| DE69920897D1 (de) | Monoklonale antikörper mit verringerter immunisierungsfähigkeit | |
| NO962346D0 (no) | Humaniserte antistoffer og anvendelser derav | |
| FI964845A7 (fi) | CD44v6:n vastaiset monoklonaaliset vasta-aineet | |
| CY2007012I1 (el) | Αντισωματα anti-vegf | |
| FI963004L (fi) | Vasta-aineen muodostumista kiihottavia monoklonaalivasta-aineita | |
| NO986050L (no) | Renset overflateantigen, monoklonalt antistoff fra spermier og anvendelse derav | |
| IL147517A0 (en) | Monoclonal antibodies and immunoassay utilizing the same | |
| DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
| HUP0103152A3 (en) | Monoclonal antibodies directed against the g3bp protein, and uses | |
| FI972430L (fi) | Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja | |
| BR9606978A (pt) | Anticorpos monoclonais antiidiótipos (ab2) e usos dos mesmos | |
| NO20011006D0 (no) | Høy-affinitets antistoffer | |
| NO20000079D0 (no) | Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav | |
| GB9718911D0 (en) | Monoclonal antibodies | |
| EP1071327A4 (en) | AUTOANTIGENT FRAGMENTS, METHODS AND ASSAYS | |
| HUP0003029A3 (en) | Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same | |
| DE69020315D1 (de) | Monoklonaler antikörper gegen c-reaktives protein. | |
| DE69427850D1 (de) | Monoklonaler antikörper gegen mucoglykoprotein | |
| BR9709080A (pt) | Anticorpo monoclonal anti-MP52 humano | |
| IT1305309B1 (it) | Procedimento per la purificazione di anticorpi anti-tireoglobulina eusi di detti anticorpi. | |
| TR199902750A3 (tr) | Anti-p53 monoklonal antikorlar ve kullanimlari. | |
| BR1100504A (pt) | anticorpos anti-ige. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |